Terms: = Kidney tumors AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Clinical Outcome
3 results:
1. Leptin Is Associated with Poor clinical outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression.
Fan WL; Yeh YM; Liu TT; Lin WM; Yang TY; Lee CW; Lin TC
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33804101
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract] [Full Text] [Related]
3. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
